The Invus Group Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • The Invus Group's estimated annual revenue is currently $15M per year.(i)
  • The Invus Group's estimated revenue per employee is $194,805

Employee Data

  • The Invus Group has 77 Employees.(i)
  • The Invus Group grew their employee count by 12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M18-14%N/AN/A
#2
N/A24-4%N/AN/A
#3
$7.5M5426%N/AN/A
#4
$11830M3644%$1MN/A
#5
$7.5M4850%$48.1MN/A
#6
$15M12317%N/AN/A
#7
N/A66-56%N/AN/A
#8
N/A27-4%N/AN/A
#9
N/A11-45%N/AN/A
#10
$7.5M504%N/AN/A
Add Company

Evergreen structure with over $5 billion under management. Offices in New York, Paris, and Hong Kong.

keywords:N/A

N/A

Total Funding

77

Number of Employees

$15M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Invus Group News

2022-04-17 - Biotech venture capital: Top 10 money-raisers of 2021

... Fidelity Management & Research Company, MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group,...

2022-04-06 - Onxeo Reports its Full-Year 2021 Financial Results and ...

- Recurring revenues corresponding to royalties on sales received by the Group pursuant to the agreement with Biogen. In 2020, these revenues...

2022-03-30 - ACTION AGAINST HUNGER WELCOMES FOUR NEW ...

... and CEO of The Invus Group, LLC, a New York-based global investment firm. ... practices of its board of directors and executive team,...

2019-09-08 - US investor joins Achilles Therapeutics £100m Series B round

... by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile Group.

2019-09-07 - UK biotech secures £100m funding for lung cancer trials

Achilles Therapeutics, a UK biotech focusing on personalised immunotherapy for cancer, has closed a £100m Series B funding round that ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.7M77-14%$7M
#2
$24.9M7726%N/A
#3
$18.7M7715%N/A
#4
$18.7M77-8%N/A
#5
$11.2M7712%N/A

The Invus Group Executives


NameTitle
Raymond DebbaneCEO/President
Angela FloreaExecutive Assistant To Chief Executive Officer
Philip BafundoChief Financial Officer
Arshaad YarChief Information Officer
Raymond DebbaneCEO/President
Chris JiangVice President, Private Equity, Asian Emerging Markets
Addy HoVP, Public Equity, Hong Kong
Jack NgVP of Finance
Georgios TheophanousVice President
Lena BeainiAssociate VP - Operations